The 2011-2016 Outlook for Multiple Myeloma Therapeutics in Africa
This econometric study covers the outlook for multiple myeloma therapeutics in Africa. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities
List Price: $ 325.00
Price: $ 325.00
The 2011-2016 Outlook for Multiple Myeloma Therapeutics in Africa
Orignal From: The 2011-2016 Outlook for Multiple Myeloma Therapeutics in Africa
No comments:
Post a Comment